Drug Discovery News on Twitter: "#SOBI to expand into #hematology & enhance US penetration by acquiring #DovaPharma $915M deal incl #thrombopoietin receptor agonist #Doptelet, currently in Ph3 #clinicaltrials vs chemo-induced #thrombocytopenia ...